These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 266972)

  • 1. Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis.
    Chary KK; Higby DJ; Henderson ES; Swinerton KD
    Cancer Treat Rep; 1977; 61(3):367-70. PubMed ID: 266972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cis-dichlorodiammineplatinum(II) in children with advanced malignant diseases: Southwest Oncology Group Studies.
    Vietti TJ; Nitschke R; Starling KA; van Eys J
    Cancer Treat Rep; 1979; 63(9-10):1611-4. PubMed ID: 291482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma.
    Ochs JJ; Freeman AI; Douglass HO; Higby DS; Mindell ER; Sinks LF
    Cancer Treat Rep; 1978 Feb; 62(2):239-45. PubMed ID: 346212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck.
    Wittes RE; Cvitkovic E; Shah J; Gerold FP; Strong EW
    Cancer Treat Rep; 1977; 61(3):359-66. PubMed ID: 872136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.
    Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM
    Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cis-Dichlorodiammineplatinum(II) and DTIC in malignant melanoma.
    Karakousis CP; Getaz EP; Bjornsson S; Henderson ES; Irequi M; Martinez L; Ospina J; Cavins J; Preisler H; Holyoke E; Holtermann O
    Cancer Treat Rep; 1979; 63(11-12):2009-10. PubMed ID: 393386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical phase I-II study of cis-dichloro-diammineplatinum(II) given by continuous lv infusion.
    Salem P; Hall SW; Benjamin RS; Murphy WK; Wharton JT; Bodey GP
    Cancer Treat Rep; 1978 Oct; 62(10):1553-5. PubMed ID: 361227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group Study.
    Samson MK; Baker LH; Benjamin RS; Lane M; Plager C
    Cancer Treat Rep; 1979; 63(11-12):2027-9. PubMed ID: 575067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study.
    Rossof AH; Coltman CA; Jones SE; Talley RW
    Cancer Treat Rep; 1979; 63(9-10):1605-8. PubMed ID: 498159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cis-Dichlorodiammineplatinum(II) in childhood cancer.
    Freeman AI; Ettinger LJ; Brecher ML
    Cancer Treat Rep; 1979; 63(9-10):1615-20. PubMed ID: 291483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cis-dichlorodiammineplatinum(II) in metastatic soft tissue sarcomas.
    Karakousis CP; Holtermann OA; Holyoke ED
    Cancer Treat Rep; 1979; 63(11-12):2071-5. PubMed ID: 393389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
    Antman K; Eder JP; Elias A; Shea T; Peters WP; Andersen J; Schryber S; Henner WD; Finberg R; Wilmore D
    Cancer Treat Rep; 1987 Feb; 71(2):119-25. PubMed ID: 3542208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer.
    Yap HY; Salem P; Hortobagyi GN; Bodey GP; Buzdar AU; Tashima CK; Blumenschein GR
    Cancer Treat Rep; 1978 Mar; 62(3):405-8. PubMed ID: 348308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary results.
    Cavalli F; Jungi WF; Sonntag RW; Nissen NI; Holland JF
    Cancer Treat Rep; 1979; 63(9-10):1599-603. PubMed ID: 227599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II evaluation of cis-dichlorodiammineplatinum(II) in advanced malignancies of the genitourinary and gynecologic organs: a Southwest Oncology Group Study.
    Rossof AH; Talley RW; Stephens R; Thigpen T; Samson MK; Groppe C; Eyre HJ; Fisher R
    Cancer Treat Rep; 1979; 63(9-10):1557-64. PubMed ID: 498155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of carboplatin (CBDCA) in children with cancer.
    Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
    Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
    Gasparini M; Rouesse J; van Oosterom A; Wagener T; Somers R; Russel JA; Voûte PA; Bramwell V; Thomas D; Sylvester R
    Cancer Treat Rep; 1985 Feb; 69(2):211-3. PubMed ID: 3855699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study.
    Al-Sarraf M; Fletcher W; Oishi N; Pugh R; Hewlett JS; Balducci L; McCracken J; Padilla F
    Cancer Treat Rep; 1982 Jan; 66(1):31-5. PubMed ID: 6796269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children.
    Kamalakar P; Freeman AI; Higby DJ; Wallace HJ; Sinks LF
    Cancer Treat Rep; 1977 Aug; 61(5):835-9. PubMed ID: 890692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.